Lisa A Conte's most recent trade in Jaguar Health Inc was a trade of 18,262 Warrant to Purchase Common Stock done . Disclosure was reported to the exchange on June 24, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Jaguar Health Inc | Lisa A. Conte | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 18,262 | 9,000 | - | - | Warrant to Purchase Common Stock | |
| Jaguar Health Inc | Lisa A. Conte | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2025 | 9,462 | 9,462 | - | - | Convertible Promissory Note | |
| Jaguar Health Inc | Lisa A. Conte | Director, CEO and President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jun 2025 | 9,000 | 0 | - | - | Convertible Promissory Note | |
| Jaguar Health Inc | Lisa A. Conte | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2025 | 2 | 0 | - | - | Restricted stock units | |
| Jaguar Health Inc | Lisa A. Conte | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2025 | 2 | 666 (0%) | 0% | - | Common Stock | |
| Jaguar Health Inc | Lisa A. Conte | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Mar 2025 | 9,000 | 9,000 | - | - | Convertible Promissory Note | |
| Jaguar Health Inc | Lisa A. Conte | Director, CEO and President | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Mar 2025 | 9,000 | 9,000 | - | - | Warrant to Purchase Common Stock | |
| Jaguar Health Inc | Lisa A. Conte | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2024 | 132,020 | 132,020 | - | - | Stock option (right to buy) | |
| Jaguar Health Inc | Lisa A. Conte | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Oct 2024 | 16,503 | 16,624 (0%) | 0% | 0 | Common Stock | |
| Jaguar Health Inc | Lisa A. Conte | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2024 | 600 | 0 | - | - | Restricted stock units | |
| Jaguar Health Inc | Lisa A. Conte | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2024 | 600 | 4,600 (0%) | 0% | - | Common Stock | |
| Jaguar Health Inc | Lisa A. Conte | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2023 | 383,605 | 387,605 (2%) | 2% | 0 | Common Stock | |
| Jaguar Health Inc | Lisa A. Conte | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2023 | 2,694 | 4,000 (0%) | 0% | - | Common Stock | |
| Jaguar Health Inc | Lisa A. Conte | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2023 | 2,694 | 5,389 | - | - | Restricted stock units | |
| Jaguar Health Inc | Lisa A. Conte | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2023 | 600 | 600 | - | - | Restricted stock units | |
| Jaguar Health Inc | Lisa A. Conte | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2023 | 600 | 1,306 (0%) | 0% | - | Common Stock | |
| Jaguar Health Inc | Lisa A. Conte | Director, CEO and President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Dec 2022 | 142,500 | 0 | - | - | Employee Stock Option (right to buy) | |
| Jaguar Health Inc | Lisa A. Conte | Director, CEO and President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Apr 2022 | 45,000 | 53,003 (0%) | 0% | - | Common Stock | |
| Jaguar Health Inc | Lisa A. Conte | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2022 | 45,000 | 90,000 | - | - | Restricted stock units | |
| Jaguar Health Inc | Lisa A Conte | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2021 | 810,000 | 810,000 | - | - | Stock option (right to buy) | |
| Jaguar Health Inc | Lisa A Conte | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Apr 2021 | 405,000 | 405,000 | - | - | Restricted stock units |